Bibliometric and visual analysis of cardiovascular diseases and COVID-19 research by Namin Wei, Yan Xu, Huan Wang, Qiulei Jia, Xintian Shou, Xuesong Zhang, Nan Zhang, Ya'nan Li, Huaqiang Zhai, Yuanhui Hu

Connect to this object online.

'Risk-benefit' assessment for comprehensive safety evaluation of Chinese patent medicines containing four common toxic ingredients: an analysis of clinical risk factors by Nan Zhang, Changming Zhong, Guoxiu Liu, Siyu Li, Li Lin, Namin Wei, Yu Song, Xiaoqing Wan, Yanping Wang, Yongyan Wang, Wanlin Wu, Zhongzhi Qian, Huaqiang Zhai

Connect to this object online.

A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China by Nan Zhang, Nannan Shi, Siyu Li, Guoxiu Liu, Yonglong Han, Li Liu, Xin Zhang, Xiangwen Kong, Bihua Zhang, Wenpeng Yuan, Yi Liu, Deqiang Deng, Minxia Zheng, Ying Zhang, Lihua Li, Xiaoping Wang, Jiankun Wu, Xiaolan Lin, Hua Nian, Xiaohong Wu, Hua Wang, Fang Liu, Hongli Wang, Hongshun Wang, Ying Liu, Li Liu, Weixin Zeng, Manqin Yang, Yanping Wang, Huaqiang Zhai, Yongyan Wang

Connect to this object online.